主页 > 医学前沿 >
【medical-news】儿童白血病治疗的新希望
Clinicians at St. Jude Children's Research Hospital have successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia.
The St. Jude technique allows blood stem cells to come from parents or unmatched adult siblings; and it avoids the aggressive, toxic treatments that usually must accompany the transplant. This allows the majority of patients with leukemia or non-cancerous blood disorders to receive a transplant, according to Gregory Hale, M.D., St. Jude Bone Marrow Transplantation Division interim chief. A report on this work appears in the prepublication edition of the British Journal of Haematology.
"Our technique also accelerated recovery of the immune system in recipients and shortened the duration of immune deficiency during the early post-transplant period, reducing the risk of infections," said Gregory Hale, M.D., St. Jude Bone Marrow Transplantation Division interim chief.
The other St. Jude authors of this paper include Xiaohua Chen, Raymond Barfield, Ely Benaim, Wing H. Leung, James Knowles, Edwin Horwitz, Paul Woodard, Kimberly Kasow, Usman Yusuf, Frederick G. Behm, Randall T. Hayden, Sheila A. Shurtleff, Victoria Turner and Deo Kumar Srivastava; and Rupert Handgretinger, formerly of St. Jude and currently at University Children's Hospital, University of Tubingen, Germany.
This work was supported in part by the National Institutes of Health, the Assisi Foundation of Memphis and ALSAC. 认领！ New Hope For Children When Leukemia Treatment Fails
白血病治疗失败儿童的新希望
Clinicians at St. Jude Children's Research Hospital have successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia.
美国St. Jude儿童研究医院的临床医生成功地证实一个改进的干细胞移植技术，对于那些很可能白血病标准治疗失败的儿童带来希望。
The St. Jude technique allows blood stem cells to come from parents or unmatched adult siblings; and it avoids the aggressive, toxic treatments that usually must accompany the transplant. This allows the majority of patients with leukemia or non-cancerous blood disorders to receive a transplant, according to Gregory Hale, M.D., St. Jude Bone Marrow Transplantation Division interim chief. A report on this work appears in the prepublication edition of the British Journal of Haematology.
这个St. Jude技术允许来源于父母或不相合的成年同胞的干细胞，它避免了移植通常伴随的破坏性的，毒性治疗。根据St. Jude骨髓移植部临时主任Gregory Hale医学博士所说，本技术使得大多数白血病或非恶性血液病患者可以接受移植。关于此的报道发表在英国血液学杂志的预印版上。
"Our technique also accelerated recovery of the immune system in recipients and shortened the duration of immune deficiency during the early post-transplant period, reducing the risk of infections," said Gregory Hale, M.D., St. Jude Bone Marrow Transplantation Division interim chief.
“我们的技术也能加速受者免疫系统的恢复，缩短移植后早期免疫缺陷持续的时间，减少感染的危险，” St. Jude骨髓移植部临时主任Gregory Hale医学博士说。
The other St. Jude authors of this paper include Xiaohua Chen, Raymond Barfield, Ely Benaim, Wing H. Leung, James Knowles, Edwin Horwitz, Paul Woodard, Kimberly Kasow, Usman Yusuf, Frederick G. Behm, Randall T. Hayden, Sheila A. Shurtleff, Victoria Turner and Deo Kumar Srivastava; and Rupert Handgretinger, formerly of St. Jude and currently at University Children's Hospital, University of Tubingen, Germany.
这篇论文的其他作者包括犹大儿童研究医院的以下人员：Xiaohua Chen, Raymond Barfield, Ely Benaim, Wing H. Leung, James Knowles, Edwin Horwitz, Paul Woodard, Kimberly Kasow, Usman Yusuf, Frederick G. Behm, Randall T. Hayden, Sheila A. Shurtleff, Victoria Turner and Deo Kumar Srivastava; 以及以前在犹大儿童研究医院，而现在在德国图宾根大学儿童医院的Rupert Handgretinger。
This work was supported in part by the National Institutes of Health, the Assisi Foundation of Memphis and ALSAC
本研究部分由国立卫生研究院，Memphis and ALSAC协助基金资助。
（具体内容不多！） 对几个词的翻译提出讨论：
St. Jude Children's Research Hospital ：美国圣犹大儿童研究医院或译为美国St. Jude儿童研究医院；
prepublication edition ：预印出版物 谢谢cplamst战友的指教，衷心感谢！ [标签:content1][标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-07-21 18:14
医学,生命科学网